Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy

Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy

Abstract Background We aimed to identify which part of the patients with metastatic renal cell carcinoma (mRCC) is not suitable for cytoreductive nephrectomy (CN). Methods The data of mRCC patients was acquired from the Surveillance, Epidemiology, and End Results (SEER) database. Multivariate cox re...

Full description

Bibliographic Details
Main Authors: Zhao Zhang, Hongliang Wu, Tong Yang, Yaohai Wu, Nengwang Yu, Zhonghua Xu
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
Renal cell carcinoma
Cytoreductive nephrectomy
Survival
SEER
Online Access:http://link.springer.com/article/10.1186/s12885-020-07351-w

Internet

http://link.springer.com/article/10.1186/s12885-020-07351-w

Similar Items